View Federal Register notices of proposed exclusive licenses. Clicking on the "View" links will display the Federal Register Notice in a new tab. You can also search directly on the Federal Register site.
Only written comments and/or application for a license which are received by the NIH Office of Technology Transfer on or before October 8, 1999 will be considered.
Only written comments and/or application for a license which are received by the NIH Office of Technology Transfer on or before September 28, 1999 will be considered.
In view of the priority for developing new antitumor agents, all proposals for either exclusive or non-exclusive licensing must be received on or before September 17, 1999.
Only written comments and/or application for a license which are received by the NIH Office of Technology Transfer on or before September 17, 1999 will be considered.
Only written comments and/or application for a license which are received by the NIH Office of Technology Transfer on or before August 31, 1999 will be considered.
Respondents interested in licensing the invention will be required to submit an ``Application for License to Public Health Service Inventions'' on or before September 20, 1999, for priority consideration.
Inquiries regarding CRADA proposals and scientific matters may be forwrded at any time. Confidential CRADA proposals, preferably two pages or less, must be submitted to the NCI within 30 days from date of this publication. Guidelines for preparing a full CRADA proposal will be communicated shortly thereafter to the respondent who has been selected.
Interested parties should notify this office in writing of their interest in filing a formal proposal no later than July 9, 1999. Potential CRADA Collaborators will then have an additional thirty (30) days to submit a formal proposal.
Interested parties should notify this office in writing of their interest in filing a formal proposal no later than June 18, 1999. They will then have an additional thirty (30) days to submit a formal proposal.
Interested parties should notify the National Cancer Institute's Technology Development & Commercialization Branch, in writing, of their intent to file a formal proposal no later than May 24, 1999. Formal proposals must be submitted to this office no later than June 7, 1999.
Only written comments and/or application for a license which are received by the NIH Office of Technology Transfer on or before July 7, 1999 will be considered.
